Hyperreflective material serves as a potential biomarker of dyslipidemia in diabetic macular edema

Photodiagnosis Photodyn Ther. 2022 Sep:39:102903. doi: 10.1016/j.pdpdt.2022.102903. Epub 2022 May 6.

Abstract

Purpose: The aim of this study was to investigate the vision-affected optical coherence tomography (angiography) (OCT/OCTA)-based morphological characteristics of diabetic macular edema (DME) and to explain their possible underlying mechanisms from a systemic perspective.

Methods: Diabetic patients with DME were included in this retrospective study. The clinical profiles and OCT/OCTA morphological characteristics were recorded. Linear mixed-model analyses were performed between best-corrected visual acuity (BCVA) and each OCT/OCTA morphological characteristic. Linear and logistic mixed-model analyses were performed between each vision-affected morphological characteristic and the clinical characteristics.

Results: Eighty-five eyes of 85 patients were included. The number of hyperreflective dots (HDs) (p<0.001) and hyperreflective foci (HF) (p = 0.006) was positively correlated with LogMAR BCVA in the univariate analysis. The number of HDs (p = 0.008) remained correlated with LogMAR BCVA in the multivariate analysis. Eyes with an increased number of HF (p = 0.01) were more likely to have hard exudates within a fovea area diameter of 3 mm, while the relationship between the number of HDs and the presence of hard exudates did not reach significance. In the multivariate analysis, the increased level of total cholesterol (TC) (p = 0.004) and the reduced level of serum albumin (p = 0.014) were associated with an increased number of HDs, and the level of serum TC (p = 0.039) was positively associated with the number of HF.

Conclusion: Hyperreflective material may be a predictor for BCVA and serves as a potential biomarker of dyslipidemia in DME. It was postulated that HF are mainly related to hard exudates and HDs are partially associated with microglial cell activation.

Keywords: Biomarker; Diabetic macular edema; Dyslipidemia; Hyperreflective material; Optical coherence tomography angiography.

MeSH terms

  • Biomarkers
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / complications
  • Diabetic Retinopathy* / diagnostic imaging
  • Diabetic Retinopathy* / drug therapy
  • Dyslipidemias* / complications
  • Humans
  • Macular Edema* / complications
  • Macular Edema* / diagnostic imaging
  • Macular Edema* / drug therapy
  • Photochemotherapy* / methods
  • Retrospective Studies
  • Tomography, Optical Coherence / methods
  • Visual Acuity

Substances

  • Biomarkers